Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
ROIV:NASDAQ
Roivant Sciences Ltd
$27.41
-2.59%
(-0.73) 1D
$27.40
-0.04% (-0.010)
Pre-market
Closed: Apr 24, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ROIV...
Open
$28.24
High
$28.32
Low
$27.06
Mkt. cap
19.62B
Avg. vol.
5.18M
Volume
968.00
52-wk high
$30.33
52-wk low
$10.58
EPS
-$1.17
Beta
1.21
Shares outstanding
715.70M
No. of employees
750
News stories
From sources across the web
Profile
Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel. Wikipedia
About Roivant Sciences Ltd
CEOMatt Gline
Employees750
FoundedApr 7, 2014
Headquarters-
SectorBiotechnology
Websiteroivant.com
Last report
Feb 6, 2026
Fiscal Period
Q3 2026
Normalized EPS / Estimate
-0.24/ (-0.31 est.)USD
+23.04%beat
Revenue / Estimate
2.00M/ (6.14M est.)USD
-67.44%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
7.57M
2.17M
1.57M
2.00M
Cost of goods sold
145.04M
152.57M
164.18M
166.08M
Cost of revenue
145.04M
152.57M
164.18M
166.08M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
227.69M
128.22M
129.52M
175.05M
Operating expense
227.69M
128.22M
129.52M
175.05M
Total operating expenses
372.74M
280.79M
293.70M
341.13M
Operating income
-365.16M
-278.62M
-292.13M
-339.14M
Other non operating income
11.28M
-13.54M
-26.65M
-16.07M
EBT including unusual items
-203.05M
-269.26M
-159.04M
-290.37M
EBT excluding unusual items
-299.26M
-243.84M
-273.44M
-311.94M
Income tax expense
49.32M
4.65M
7.00M
23.33M
Effective tax rate
-24.29%
-1.73%
-4.40%
-8.04%
Other operating expenses
-
-
-
-
Net income
-206.48M
-223.36M
-113.52M
-265.89M
Net profit margin
-2,727.54%
-10,292.86%
-7,225.91%
-13,301.20%
Earnings per share
-0.22
-0.25
-0.28
-0.24
Interest and investment income
54.62M
48.32M
45.34M
43.27M
Interest expense
-
-
-
-
Net interest expenses
54.62M
48.32M
45.34M
43.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-357.00M
-277.52M
-291.21M
-338.44M
Gain or loss from assets sale
-3.11M
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer